PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, presenting promising progress across different health care and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, additional responsible alternate for therapeutic use, particul